Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1939-4551
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review ; volume:7 ; number:1 ; day:31 ; month:12 ; year:2014 ; pages:1-13 ; date:12.2014
World Allergy Organization journal / World Allergy Organization ; 7, Heft 1 (31.12.2014), 1-13, 12.2014
- Creator
-
Carrillo, Diana C.
- Contributor
-
Borges, Mario Sanchez
Garcia, Elizabeth
Egea, Eduardo
Serrano, Carlos D.
SpringerLink (Online service)
- DOI
-
10.1186/s40413-014-0050-z
- URN
-
urn:nbn:de:1111-2016073157658
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Carrillo, Diana C.
- Borges, Mario Sanchez
- Garcia, Elizabeth
- Egea, Eduardo
- Serrano, Carlos D.
- SpringerLink (Online service)
Other Objects (12)
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
Long term treatment with omalizumab in adolescent with refractory solar urticaria
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Real-World Effectiveness of Omalizumab in Chronic Urticaria: A Clinical Observational Study
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
A Case of α-Gal-Unrelated Red Meat-Induced Urticaria Treated by Omalizumab
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
Long term treatment with omalizumab in adolescent with refractory solar urticaria
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Real-World Effectiveness of Omalizumab in Chronic Urticaria: A Clinical Observational Study
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
A Case of α-Gal-Unrelated Red Meat-Induced Urticaria Treated by Omalizumab
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
Long term treatment with omalizumab in adolescent with refractory solar urticaria
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Real-World Effectiveness of Omalizumab in Chronic Urticaria: A Clinical Observational Study
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status